Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 12 Next »

4Meeting Name:

ELR Open Call #131

Moderator:

Vanessa Holley

Date:

Thursday, February 22, 2024

Notes:

Ray Lewis

Duration:

55 Minutes

Attendees:

Zoom Link:

Meeting Zoom Link Meeting ID: 940 4241 0458, Dial: (312) 626-6799

Recording Link

https://youtu.be/uRHHvfZFUE0

Zoom Chat Notes:

Propose Topics

ELR Open Forum Proposed Topics

Past Meeting Recordings & Notes

ELR Open Forum Dashboard - Weekly Agenda

Agenda

Presenter/Facilitator

Topic

ONC

CDC

USCDI+ and USCDI v5 Discussion

Vanessa Holley, APHL

Questions/Updates

Notes:

Presenter/Facilitator

Topic

Discussion:

Action Items

ONC

CDC

USCDI+ and USCDI v5 Discussion

USCDI plus comments were due March 4.

USCDI Version 5 comments are due Monday April 15.

ONC (Al Taylor and Kathleen (Katie) Tully)

Draft USCDI Version 5

What is USCDI?

Comprises a core set of data needed to support patient care and facilitate patient access using health IT. USCDI establishes a consistent baseline of data for other use cases. They expand over time via a predictable, transparent, and collaborative public access.

ONC Cures Act Final Rule established USCDI v1 in 2020.

ONDEC Submission System-Anyone can submit a new data idea to this system.

ONDEC Levelling Criteria (0,1, and 2) Readiness, Feasibility, and applicability of data. The 4th category is breath of applicability.

Prioritization criteria for new USCDI Data Elements-Public Health, Underserved communities, Healthcare disparities and inequities, Behavioral health, and Key additions over past USCDI versions.

New Data Elements in Draft USCDI v5-Clinical Notes(Emergency Department Note, Operative Note), Medication (Route), Immunizations (Lot Number), Laboratory (Test kit Unique Device Identifier), New Data Class (Observations (Advance directive observation and Sex Parameter for clinical use)), New Data Class Orders, Provenance (Author and Author Role), and Patient Demographics Information (pronoun, Name to use, and Interpreter needed).

USCDI Plus (plus)-intended to extend beyond USCDI. It was established for public health to think about how we can extend USCDI to meet more program or use case specific needs.

USCDI Plus is more flexible with how they approach their update cycles (Iterative and Rolling Process).

Core USCDI plus principles-Ensure harmonization across all data elements in USCID and USCDI plus domains (e.g. public health, maternal health, quality, and cancer)

USCDI Plus Public Health-Capture the data needs of public health that fall outside of the scope of USCDI; improve data quality and availability.

Current Use Cases-Case Reporting, Immunization Data Exchange, Resource Reporting and Situational Awareness, Laboratory Data Exchange, and Risk Behaviors and Health Equity

Feeback Requested-Laboratory Data Exchange- 1. What additional data elements should be included in this dataset to support these use cases? 2. What data elements may be unnecessary outside of the COVID-19 pandemic? 3. What additional laboratory data exchange use cases may be valuable to include within the dataset?

Feedback Requested-Case Reporting-Public Health are their data elements that are coming across as “Null” consistently?

ue

Questions and Comments

Riki: the lab use case is under public health - does that mean it is limited to the exchange from lab to PH, or ANY lab results? Katie-We are thinking about it from the exchange of data in between public health and labs.

Kevin Weitemier (Oregon PHL): Does USCDI+ Public Health include newborn screening programs? Katie-Yes, if that is something that is important to include in scope of lab. Please comment.

Riki: Need to get a better understanding of what the boundaries are between the different domains: how does cancer and laboratory interact with each other - and also laboratory and Real world data? Katie-For this data set, lab being a data set within public health, we are going to be navigating as we move along. We can see a

Other Discussion/Updates

Vanessa Holley, APHL

  • No labels